These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 26060475)
1. In vitro evidence of baicalein's inhibition of the metabolism of zidovudine (AZT). Wang YC; Yang HY; Kong LT; Yu FX Afr Health Sci; 2014 Mar; 14(1):173-7. PubMed ID: 26060475 [TBL] [Abstract][Full Text] [Related]
2. In vitro evidence for endocrine-disrupting chemical (EDC)'s inhibition of drug metabolism. Li WP; Wang YF; Gao J; Yu ML; Yu YY; Yao YQ Afr Health Sci; 2014 Mar; 14(1):185-8. PubMed ID: 26060477 [TBL] [Abstract][Full Text] [Related]
3. Biotransformation of baicalin to baicalein significantly strengthens the inhibition potential towards UDP-glucuronosyltransferases (UGTs) isoforms. Teng Y; Nian H; Zhao H; Chen P; Wang G Pharmazie; 2013 Sep; 68(9):763-7. PubMed ID: 24147345 [TBL] [Abstract][Full Text] [Related]
4. In vitro evidence for bakuchiol's influence towards drug metabolism through inhibition of UDP-glucuronosyltransferase (UGT) 2B7. Xu Y; Li P; Zhang X; Wang J; Gu D; Wang Y Afr Health Sci; 2014 Sep; 14(3):564-9. PubMed ID: 25352873 [TBL] [Abstract][Full Text] [Related]
5. In vitro-in vivo correlations for drugs eliminated by glucuronidation: investigations with the model substrate zidovudine. Boase S; Miners JO Br J Clin Pharmacol; 2002 Nov; 54(5):493-503. PubMed ID: 12445028 [TBL] [Abstract][Full Text] [Related]
6. Quantitative prediction of in vivo inhibitory interactions involving glucuronidated drugs from in vitro data: the effect of fluconazole on zidovudine glucuronidation. Uchaipichat V; Winner LK; Mackenzie PI; Elliot DJ; Williams JA; Miners JO Br J Clin Pharmacol; 2006 Apr; 61(4):427-39. PubMed ID: 16542204 [TBL] [Abstract][Full Text] [Related]
7. Comparison of inhibition potentials of drugs against zidovudine glucuronidation in rat hepatocytes and liver microsomes. Mano Y; Usui T; Kamimura H Drug Metab Dispos; 2007 Apr; 35(4):602-6. PubMed ID: 17267620 [TBL] [Abstract][Full Text] [Related]
8. Warfarin is an effective modifier of multiple UDP-glucuronosyltransferase enzymes: evaluation of its potential to alter the pharmacokinetics of zidovudine. Sun H; Zhang T; Wu Z; Wu B J Pharm Sci; 2015 Jan; 104(1):244-56. PubMed ID: 25393417 [TBL] [Abstract][Full Text] [Related]
9. Glucuronidation of 3'-azido-3'-deoxythymidine (zidovudine) by human liver microsomes: relevance to clinical pharmacokinetic interactions with atovaquone, fluconazole, methadone, and valproic acid. Trapnell CB; Klecker RW; Jamis-Dow C; Collins JM Antimicrob Agents Chemother; 1998 Jul; 42(7):1592-6. PubMed ID: 9660989 [TBL] [Abstract][Full Text] [Related]
10. Altered AZT (3'-azido-3'-deoxythymidine) glucuronidation kinetics in liver microsomes as an explanation for underprediction of in vivo clearance: comparison to hepatocytes and effect of incubation environment. Engtrakul JJ; Foti RS; Strelevitz TJ; Fisher MB Drug Metab Dispos; 2005 Nov; 33(11):1621-7. PubMed ID: 16049128 [TBL] [Abstract][Full Text] [Related]
12. Transmitted human immunodeficiency virus type 1 carrying the D67N or K219Q/E mutation evolves rapidly to zidovudine resistance in vitro and shows a high replicative fitness in the presence of zidovudine. García-Lerma JG; MacInnes H; Bennett D; Weinstock H; Heneine W J Virol; 2004 Jul; 78(14):7545-52. PubMed ID: 15220429 [TBL] [Abstract][Full Text] [Related]
13. In vitro and in situ evaluation of herb-drug interactions during intestinal metabolism and absorption of baicalein. Fong YK; Li CR; Wo SK; Wang S; Zhou L; Zhang L; Lin G; Zuo Z J Ethnopharmacol; 2012 Jun; 141(2):742-53. PubMed ID: 21906668 [TBL] [Abstract][Full Text] [Related]
14. Effect of anticancer drugs on the glucuronidation of 3'-azido-3'-deoxythymidine in human liver microsomes. Rajaonarison JF; Lacarelle B; Catalin J; Durand A; Cano JP Drug Metab Dispos; 1993; 21(5):823-9. PubMed ID: 7902243 [TBL] [Abstract][Full Text] [Related]
15. Interaction of AZT with human serum albumin studied by capillary electrophoresis, FTIR and CD spectroscopic methods. Gaudreau S; Neault JF; Tajmir-Riahi HA J Biomol Struct Dyn; 2002 Jun; 19(6):1007-14. PubMed ID: 12023803 [TBL] [Abstract][Full Text] [Related]
16. Selective excision of AZTMP by drug-resistant human immunodeficiency virus reverse transcriptase. Boyer PL; Sarafianos SG; Arnold E; Hughes SH J Virol; 2001 May; 75(10):4832-42. PubMed ID: 11312355 [TBL] [Abstract][Full Text] [Related]
18. Selective inhibition of the cytochrome P450 isoform by hyperoside and its potent inhibition of CYP2D6. Song M; Hong M; Lee MY; Jee JG; Lee YM; Bae JS; Jeong TC; Lee S Food Chem Toxicol; 2013 Sep; 59():549-53. PubMed ID: 23835282 [TBL] [Abstract][Full Text] [Related]
19. 3'-azido-3'-deoxythymidine drug interactions. Screening for inhibitors in human liver microsomes. Rajaonarison JF; Lacarelle B; Catalin J; Placidi M; Rahmani R Drug Metab Dispos; 1992; 20(4):578-84. PubMed ID: 1356738 [TBL] [Abstract][Full Text] [Related]
20. The effect of various drugs on the glucuronidation of zidovudine (azidothymidine; AZT) by human liver microsomes. Sim SM; Back DJ; Breckenridge AM Br J Clin Pharmacol; 1991 Jul; 32(1):17-21. PubMed ID: 1909542 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]